FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileElevance Health Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
Back to Elevance Health Inc.

Elevance Health Inc. (ELV) analyst ratings and price targets

The latest rating and price-target changes from Wall Street analysts, newest first — the firm, the analyst, and the article each one was published in.

Average 12-month target $463.50 · Consensus Buy (19 analysts)

Firm · analystDateRatingPrice targetSource
Argus ResearchDavid ToungNov 18, 2026—$510.00from $465.00StreetInsider ↗
Wells FargoOct 27, 2026MaintainsOverweight——
Piper SandlerOct 23, 2026—$520.00from $409.00StreetInsider ↗
TD CowenOct 23, 2026MaintainsBuy$495.00TheFly ↗
Mizuho SecuritiesAnn HynesOct 23, 2026—$490.00from $465.00TheFly ↗
Goldman SachsOct 23, 2026—$451.00from $395.00TheFly ↗
UBSOct 22, 2026MaintainsBuy$523.00from $460.00TheFly ↗
RBC CapitalOct 22, 2026MaintainsSector Perform$455.00from $424.00TheFly ↗
Bank of America SecuritiesKevin FischbeckOct 22, 2026—$500.00TheFly ↗
GuggenheimJason CassorlaOct 22, 2026MaintainsBuy$485.00from $460.00TheFly ↗
Robert W. BairdOct 22, 2026—$406.00from $393.00TheFly ↗
BarclaysOct 22, 2026MaintainsOverweight$472.00from $469.00TheFly ↗
BairdOct 22, 2026MaintainsNeutral——
Morgan StanleyOct 22, 2026MaintainsEqual Weight——
GuggenheimJason CassorlaOct 12, 2026MaintainsBuy$460.00from $455.00StreetInsider ↗

Source: Wall Street analysts' published price targets and ratings, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.